Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 9, 2014, Pages 1840-1850

  Dostalikova Cimburova, Marketa ^a   Balusikova, Kamila ^a   Kratka, Karolina ^a   Chmelikova, Jitka ^a   Hejda, Vaclav ^a   Hnanicek, Jan ^a   Neubauerova, Jitka ^a   Vranova, Jana ^a   Kovar, Jan ^a   Horak, Jiri ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Alcoholic liver disease; DCYTB; DMT1; FPN1; Gene expression; Hepcidin; HEPH; HFE; Iron; TFR1

Indexed keywords

CATION TRANSPORT PROTEIN; CYBRD1 PROTEIN, HUMAN; CYTOCHROME B; HEPCIDIN; HEPH PROTEIN, HUMAN; IRON; MEMBRANE PROTEIN; METAL TRANSPORTING PROTEIN 1; OXIDOREDUCTASE; SOLUTE CARRIER FAMILY 11- (PROTON-COUPLED DIVALENT METAL ION TRANSPORTERS), MEMBER 2;

ADULT; AGED; ALCOHOL LIVER DISEASE; BLOOD; CASE CONTROL STUDY; DUODENUM; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; CYTOCHROME B GROUP; DUODENUM; FEMALE; GENE EXPRESSION; HEPCIDINS; HUMANS; IRON; LIVER DISEASES, ALCOHOLIC; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OXIDOREDUCTASES;

EID: 84908247563     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12310     Document Type: Article

References (62)

1. Chapman RW, Morgan MY, Laulicht M, et al. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci. 1982; 27: 909-16.
2. Latvala J, Parkkila S, Niemelä O. Excess alcohol consumption is common in patients with cytopenia: studies in blood and bone marrow cells. Alcohol Clin Exp Res. 2004; 28: 619-24.
3. Whitfield JB, Zhu G, Heath AC, et al. Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers. Alcohol Clin Exp Res. 2001; 25: 1037-45.
4. Lembke A, Bradley KA, Henderson P, et al. Alcohol screening scores and the risk of new-onset gastrointestinal illness or related hospitalization. J Gen Intern Med. 2011; 26: 777-82.
5. Le Moine O, Hadengue A, Moreau R, et al. Relationship between portal pressure, esophageal varices, and variceal bleeding on the basis of the stage and cause of cirrhosis. Scand J Gastroenterol. 1997; 32: 731-5.
6. McCormick PA, Walker S, Benepal R. Hypersplenism is related to age of onset of liver disease. Ir J Med Sci. 2007; 176: 293-6.
7. Stanley AJ, Robinson I, Forrest EH, et al. Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. Q J Med. 1998; 91: 19-25.
8. Toghill PJ, Green S. Splenic influences on the blood in chronic liver disease. Q J Med. 1979; 48: 613-25.
9. Maruyama S, Hirayama C, Yamamoto S, et al. Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med. 2001; 138: 332-7.
10. Gonzalez-Casas R, Jones EA, Moreno-Otero R. Spectrum of anemia associated with chronic liver disease. World J Gastroenterol. 2009; 15: 4653-8.
11. Lewis G, Wise MP, Poynton C, et al. A case of persistent anemia and alcohol abuse. Nat Clin Pract Gastroenterol Hepatol. 2007; 4: 521-6.
12. Gleeson D, Evans S, Bradley M, et al. HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls. Am J Gastroenterol. 2006; 101: 304-10.
13. Ioannou GN, Dominitz JA, Weiss NS, et al. The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology. 2004; 126: 1293-301.
14. Duane P, Raja KB, Simpson RJ, et al. Intestinal iron absorption in chronic alcoholics. Alcohol Alcohol. 1992; 27: 539-44.
15. Sumida Y, Nakashima T, Yoh T, et al. Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases. Liver. 2001; 21: 295-9.
16. Winterbourn CC. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol Lett. 1995; 82-83: 969-74.
17. Xu Y, Feng Y, Li H, et al. Ferric citrate CYP2E1-independently promotes alcohol-induced apoptosis in HepG2 cells via oxidative/nitrative stress which is attenuated by pretreatment with baicalin. Food Chem Toxicol. 2012; 50: 3264-72.
18. McKie AT, Barrow D, Latunde-Dada GO, et al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science. 2001; 291: 1755-9.
19. Fleming MD, Trenor CC, Su MA, et al. Microcytic anemia mice have a mutation in Nramp2, a candidate iron transporter. Nat Genet. 1997; 16: 383-6.
20. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997; 388: 482-8.
21. Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J BiolChem. 2000; 275: 19906-12.
22. Donovan A, Brownlie A, Zhou Y, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000; 403: 776-81.
23. McKie AT, Marciani P, Rolfs A, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000; 5: 299-309.
24. Harris ZL, Durley AP, Man TK, et al. Targeted gene disruption reveals an essential rolefor ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA. 1999; 96: 10812-7.
25. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996; 13: 399-408.
26. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA. 1998; 95: 1472-7.
27. Parkkila S, Waheed A, Britton RS, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA. 1997; 94: 13198-202.
28. Goswami T, Andrews NC. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem. 2006; 281: 28494-8.
29. Gao J, Chen J, Kramer M, et al. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab. 2009; 9: 217-27.
30. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002; 110: 1037-44.
31. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306: 2090-3.
32. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr. 2006; 26: 323-42.
33. Mena NP, Esparza A, Tapia V, et al. Hepcidin inhibits apical iron uptake in intestinal cells. Am J Physiol Gastrointest Liver Physiol. 2008; 294: G192-8.
34. Frazer DM, Wilkins SJ, Becker EM, et al. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology. 2002; 123: 835-44.
35. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA. 2001; 98: 8780-5.
36. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001; 276: 7811-9.
37. Bridle KR, Frazer DM, Wilkins SJ, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet. 2003; 361: 669-73.
38. Kemna EH, Tjalsma H, Podust VN, et al. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem. 2007; 53: 620-8.
39. Nemeth E, Roetto A, Garozzo G, et al. Hepcidin is decreased in TFR2 hemochromatosis. Blood. 2005; 105: 1803-6.
40. Bridle K, Cheung TK, Murphy T, et al. Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin Exp Res. 2006; 30: 106-12.
41. Harrison-Findik DD, Schafer D, Klein E, et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem. 2006; 281: 22974-82.
42. Harrison-Findik DD, Klein E, Crist C, et al. Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol. Hepatology. 2007; 46: 1979-85.
43. Heritage ML, Murphy TL, Bridle KR, et al. Hepcidin regulation in wild-type and Hfe knockout mice in response to alcohol consumption: evidence for an alcohol-induced hypoxic response. Alcohol Clin Exp Res. 2009; 33: 1391-400.
44. Dostalikova-Cimburova M, Kratka K, Balusikova K, et al. Duodenal expression of iron transport molecules in patients with hereditary hemochromatosis or iron deficiency. J Cell Mol Med. 2012; 16: 1816-26.
45. Cimburova M, Putova I, Provaznikova H, et al. S65C and other mutations in the haemochromatosis gene in the Czech population. Folia Biol (Praha). 2005; 51: 172-6.
46. Kovar J, Neubauerova J, Cimburova M, et al. Stimulation of non-transferrin iron uptake by iron deprivation in K562 cells. Blood Cells Mol Dis. 2006; 37: 95-9.
47. Hubert N, Hentze MW. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci USA. 2002; 99: 12345-50.
48. Galy B, Ferring-Appel D, Kaden S, et al. Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. Cell Metab. 2008; 7: 79-85.
49. Foot NJ, Dalton HE, Shearwin-Whyatt LM, et al. Regulation of the divalent metal ion transporter DMT1 and iron homeostasis by a ubiquitin-dependent mechanism involving Ndfips and WWP2. Blood. 2008; 112: 4268-75.
50. Okazaki Y, Ma Z, Yeh M, et al. DMT1 (IRE) expression in intestinal and erythroid cells is regulated by peripheral benzodiazepine receptor-associated protein 7. Am J Physiol Gastrointest Liver Physiol. 2012; 302: G1180-90.
51. Andolfo I, De Falco L, Asci R, et al. Regulation of divalent metal transporter 1 (DMT1) non-IRE isoform by the microRNA Let-7d in erythroid cells. Haematologica. 2010; 95: 1244-52.
52. Kelleher T, Ryan E, Barrett S, et al. Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis. Gut. 2004; 53: 1174-9.
53. Nelson JE, Mugford VR, Kilcourse E, et al. Relationship between gene expression of duodenal iron transporters and iron stores in hemochromatosis subjects. Am J Physiol Gastrointest Liver Physiol. 2010; 298: G57-62.
54. Stuart KA, Anderson GJ, Frazer DM, et al. Duodenal expression of iron transport molecules in untreated haemochromatosis subjects. Gut. 2003; 52: 953-9.
55. Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications. J Hepatol. 2011; 54: 173-81.
56. Viatte L, Vaulont S. Hepcidin, the iron watcher. Biochimie. 2009; 91: 1223-8.
57. Theurl I, Aigner E, Theurl M, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009; 113: 5277-86.
58. Pinto JP, Ribeiro S, Pontes H, et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood. 2008; 111: 5727-33.
59. Pietrangelo A, Rocchi E, Casalgrandi G, et al. Regulation of transferrin, transferrin receptor, and ferritin genes in human duodenum. Gastroenterology. 1992; 102: 802-9.
60. Kohgo Y, Ohtake T, Ikuta K, et al. Iron accumulation in alcoholic liver diseases. Alcohol Clin Exp Res. 2005; 29: 189S-93S.
61. Suzuki Y, Saito H, Suzuki M, et al. Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease. Alcohol Clin Exp Res. 2002; 26: 26S-31S.
62. Stuart KA, Anderson GJ, Frazer DM, et al. Increased duodenal expression of divalent metal transporter 1 and iron-regulated gene 1 in cirrhosis. Hepatology. 2004; 39: 492-9.